The pharmacy manager of JNT Pharmacy in Brewster, N.Y., allegedly stole and resold more than $50,000 worth of diabetic test strips, according to the Times Herald-Record.
Pharmacy
Pfizer will pay $975,000 to settle allegations that it misled customers with its copay coupon program, according to a STAT news report.
Citing headwinds in the U.S. generic drug market, Lupin Pharmaceuticals plans to lay off more than 60 employees from its research and development team, according to The Economic Times.
Roche's blockbuster breast cancer treatment Herceptin will face more competition after Pfizer's biosimilar won FDA approval March 11, according to Reuters.
Hospitals around the country have been jumping at the opportunity to offer patients CAR-T therapy, an often last-ditch effort to fight cancer. While the cutting-edge therapy has shown a lot of promise to save lives, it also leaves hospitals grappling…
An Oklahoma judge refused Purdue Pharma, Johnson & Johnson & Teva Pharmaceutical's request to delay a trial that accuses them of fueling the opioid crisis last week. Afterward, Purdue Pharma said its decision on whether to file for bankruptcy won't…
After recent reports that infamous "pharma bro" Martin Shkreli was running his pharmaceutical company from behind bars using a contraband cellphone, the U.S. Bureau of Prisons is investigating, according to The Wall Street Journal.
ABC News and 20/20 will release a two-hour documentary March 15 on the catastrophic fate of Theranos, the tech startup that promised to revolutionize the healthcare industry, and its disgraced founder, according to RollingStone.
Personal genetics company 23andMe is betting that its at-home DNA testing kit can help users identify the likelihood of developing diabetes.
Most members of the drug supply chain, including manufacturers, pharmacies, pharmacy benefit managers and payers, are cashing in on the rising costs of prescription drugs, a new Pew Charitable Trusts research report suggests.